X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-11-17 | HRTX | Forbes William P | EVP, Chief Development Officer | P - Purchase | $1.09 | +25,000 | 79,000 | +46% | +$27,250 | ||||||
2023-11-16 | HRTX | Forbes William P | EVP, Chief Development Officer | P - Purchase | $0.94 | +50,000 | 54,000 | >999% | +$46,995 | ||||||
2023-11-16 | HRTX | Collard Craig A | CEO | P - Purchase | $0.92 | +150,000 | 186,496 | +411% | +$137,970 | ||||||
2023-11-16 | HRTX | Duarte IRA | EVP, CFO | P - Purchase | $0.89 | +85,000 | 85,000 | New | +$75,599 | ||||||
| D | 2023-07-21 | HRTX | Morgan Adam | Dir | P - Purchase | $1.37 | +2,486,744 | 7,024,623 | +55% | +$3,406,839 | |||||
2022-05-03 | HRTX | Manhard Kimberly | EVP, Drug Development | S - Sale | $4.76 | -1,504 | 10,872 | -12% | -$7,154 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |